F. Lampert
About
In The Last Decade
F. Lampert
129 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 111
- Public Health, Environmental and Occupational Health 1.4k
- Hematology 1.3k
- Molecular Biology 1.2k
- Neurology 586
- Pediatrics, Perinatology and Child Health 565
Countries citing papers authored by F. Lampert
This map shows the geographic impact of F. Lampert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Lampert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Lampert more than expected).
Fields of papers citing papers by F. Lampert
This network shows the impact of papers produced by F. Lampert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Lampert. The network helps show where F. Lampert may publish in the future.
Co-authorship network of co-authors of F. Lampert
This figure shows the co-authorship network connecting the top 25 collaborators of F. Lampert. A scholar is included among the top collaborators of F. Lampert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Lampert. F. Lampert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 31 | |
| 2 | 62 | |
| 3 | Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92. | 103 |
| 4 | 31 | |
| 5 | A novel type of MLL/AF10 fusion transcript in a child with acute megakaryocytic leukemia (AML-M7) | 18 |
| 6 | 7 | |
| 7 | 39 | |
| 8 | 14 | |
| 9 | Chromosome 1 interphase-cytogenetics in 32 primary neuroblastomas of different clinical stages. | 6 |
| 10 | 40 | |
| 11 | 125 | |
| 12 | 4 | |
| 13 | 2 | |
| 14 | 17 | |
| 15 | 60 | |
| 16 | 18 | |
| 17 | 5 | |
| 18 | [ALL therapy study 1971-1974 of the German working group for leukemia research and therapy in childhood: prognostic significance of initial features and different therapeutic modalities (author's transl)]. | 4 |
| 19 | Improvements of the electrophoretic mobility test to measure lymphocyte sensitization. | 0 |
| 20 | [Acute lymphoblastic leukemia after tuberculosis in a 8-year old greek boy with homozygous beta-thalassemia (author's transl)]. | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.